Skip to main content
Log in

Perspectives and Risks of Breast-Conservation Therapy for Breast Cancer

  • Editorials
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer Statistics, 2003. CA Cancer J Clin 2003; 53: 5–26.

    Article  PubMed  Google Scholar 

  2. Elisaf M, Roukos DH, Briasoulis E, Michos KM, Agnantis NJ, Kappas AM. Comparing recent advances in gastric and breast cancer. Gastric Breast Cancer 2002; 1: 59–64.

    Google Scholar 

  3. Morrow M, Strom EA, Bassett LW, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 2002; 52: 277–300.

    Article  PubMed  Google Scholar 

  4. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233–41.

    Article  PubMed  Google Scholar 

  5. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227–32.

    Article  PubMed  Google Scholar 

  6. Morrow M. Rational local therapy for breast cancer. N Engl J Med 2002; 347: 1270–1.

    Article  PubMed  Google Scholar 

  7. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000; 92: 1143–50.

    Article  PubMed  CAS  Google Scholar 

  8. Freedman GM, Hanlon AL, Fowble BL, Anderson PR, Nikolaou N. Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation. J Clin Oncol 2002; 20: 4015–21.

    Article  PubMed  CAS  Google Scholar 

  9. Neuschatz AC, DiPetrillo T, Safaii H, et al. Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer 2003; 97: 30–9.

    Article  PubMed  Google Scholar 

  10. Roukos DH, Agnantis NJ, Batsis H, Paraskevaidis E, Kappas AM. Breast-conserving surgery and risk of positive margins in breast cancer. Gastric Breast Cancer 2003;2:15–9. Available at: http://www.gastriccancer.net/Margins_abs.asp.

    Google Scholar 

  11. Smitt MC, Nowels KW, Zdeblich MJ, et al. The important of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995; 76: 259–67.

    Article  PubMed  CAS  Google Scholar 

  12. Park C, Mitsumori M, Recht A, et al. The relationship between pathologic margin status and outcome after breast-conserving therapy. Int J Radiat Oncol Biol Phys 1998; 42: 125.

    Google Scholar 

  13. Cowen D, Houvenaeghel G, Bardou V-J, et al. Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer. Int J Radiat Oncol Biol Phys 2000; 47: 305–12.

    Article  PubMed  CAS  Google Scholar 

  14. Padera TP, Kadambi A, di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumour lymphatics. Science 2002; 296: 1883–6.

    Article  PubMed  CAS  Google Scholar 

  15. Peterson ME, Schultz DJ, Reynolds C, et al. Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 1999; 43: 1029–35.

    Article  PubMed  CAS  Google Scholar 

  16. National Surgical Adjuvant Breast and Bowel Project. NSABP Progress Report 2001. Pittsburgh: National Surgical Adjuvant Breast and Bowel Project, 2002:84, 94, 140.

  17. Fisher B, Dignam J, Bryant J, et al. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst 1996; 88: 1529–42.

    Article  PubMed  CAS  Google Scholar 

  18. Dalberg K, Johansson H, Johansson U, et al. A randomized trial of long-term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy for patients with early-stage breast carcinoma treated with breast-conserving surgery. Cancer 1998; 82: 2204—11.

    Article  PubMed  CAS  Google Scholar 

  19. Smith TE, Lee D, Turner BC, Carter B, Haffty BG. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 2000; 481: 281–9.

    Google Scholar 

  20. Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345: 1378–87.

    Article  PubMed  CAS  Google Scholar 

  21. Black N. Evidence-based surgery: a passing fad? World J Surg 1999; 23: 789–93.

    Article  PubMed  CAS  Google Scholar 

  22. Early Breast Cancer Trialists’ Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000; 355: 1757–70.

    Article  Google Scholar 

  23. Kurtz JM, Jacquemier J, Amalric R, et al. Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 1990; 8: 591–8.

    PubMed  CAS  Google Scholar 

  24. Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995; 196: 115–22.

    PubMed  CAS  Google Scholar 

  25. van de Vijver MJ, He YD, van’t Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999–2009.

    Article  PubMed  CAS  Google Scholar 

  26. Keyomarsi K, Tucker SL, Buchholz TA, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002; 347: 1566–75.

    Article  PubMed  CAS  Google Scholar 

  27. Roukos DH, Agnantis NJ. Gene-expression profile: the future in the outcome prediction and treatment of breast cancer. Gastric Brteast Cancer 2003;2:5–8. Available at: http://www.gastriccancer.net/ Gene-Expression_abs.asp.

    Google Scholar 

  28. Agnantis NJ, Roukos DH. Cyclin E: a new biologic prognostic marker for breast cancer? Gastric Breast Cancer 2003;2:9–11. Available at: http://www.gastriccancer.net/Cyclin_abs.asp.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dimitrios H. Roukos MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roukos, D.H., Kappas, A.M. & Agnantis, N.J. Perspectives and Risks of Breast-Conservation Therapy for Breast Cancer. Ann Surg Oncol 10, 718–721 (2003). https://doi.org/10.1245/ASO.2003.05.925

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.05.925

Navigation